A @SciImmunology study in mice suggests that targeting a gene linked to prostate tumorigenesis can make the disease more responsive to immunotherapy including adoptive T cell therapy, immune checkpoint blockade, and CXCR2 inhibition.

📄: https://t.co/mts2llwzaS https://t.co/KNACxGXBbz

This was tweeted by Science Magazine.

Leave a Reply

Your email address will not be published. Required fields are marked *